Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Cellectis S.A.

CMVLFPNK
Healthcare
Biotechnology
$4.50
$0.10(2.27%)
U.S. Market opens in 9h 46m

Cellectis S.A. (CMVLF) Stock Overview

Explore Cellectis S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap325.5M
P/E Ratio-12.77
EPS (TTM)$-0.33
ROE-0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$4.51
3 Months$5.18
1 Year Target$6.05

CMVLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellectis S.A. (CMVLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.77 and a market capitalization of 325.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
2.27%
1-Month Change
2.27%
3-Month Change
N/A
6-Month Change
44.23%
Year-to-Date (YTD) Change
2.27%
1-Year Change
260.00%
3-Year Change
87.50%
5-Year Change
-79.06%
All-Time (Max) Change
-66.42%

Contact Information

33 1 81 69 16 00
8, rue de la Croix Jarry, Paris, NaN, 75013

Company Facts

2,160 Employees
IPO DateJul 1, 2014
CountryFR
Actively Trading

Frequently Asked Questions